nodes	percent_of_prediction	percent_of_DWPC	metapath
Pasireotide—SSTR5—hindbrain—brain cancer	0.0496	0.0857	CbGeAlD
Pasireotide—SSTR3—hindbrain—brain cancer	0.0475	0.0822	CbGeAlD
Pasireotide—SSTR1—hindbrain—brain cancer	0.0376	0.0649	CbGeAlD
Pasireotide—SSTR2—hindbrain—brain cancer	0.0319	0.0552	CbGeAlD
Pasireotide—SSTR5—brainstem—brain cancer	0.0284	0.0491	CbGeAlD
Pasireotide—SSTR3—brainstem—brain cancer	0.0272	0.0471	CbGeAlD
Pasireotide—SSTR1—brainstem—brain cancer	0.0215	0.0372	CbGeAlD
Pasireotide—SSTR5—pituitary gland—brain cancer	0.0205	0.0355	CbGeAlD
Pasireotide—SSTR3—pituitary gland—brain cancer	0.0197	0.034	CbGeAlD
Pasireotide—SSTR1—telencephalon—brain cancer	0.0191	0.033	CbGeAlD
Pasireotide—SSTR2—brainstem—brain cancer	0.0183	0.0317	CbGeAlD
Pasireotide—SSTR2—telencephalon—brain cancer	0.0162	0.0281	CbGeAlD
Pasireotide—SSTR5—endocrine gland—brain cancer	0.0159	0.0275	CbGeAlD
Pasireotide—SSTR1—pituitary gland—brain cancer	0.0156	0.0269	CbGeAlD
Pasireotide—SSTR3—endocrine gland—brain cancer	0.0152	0.0264	CbGeAlD
Pasireotide—SSTR3—head—brain cancer	0.0151	0.026	CbGeAlD
Pasireotide—SSTR5—cerebellum—brain cancer	0.014	0.0242	CbGeAlD
Pasireotide—SSTR3—central nervous system—brain cancer	0.0137	0.0238	CbGeAlD
Pasireotide—SSTR1—midbrain—brain cancer	0.0137	0.0237	CbGeAlD
Pasireotide—SSTR3—cerebellum—brain cancer	0.0134	0.0232	CbGeAlD
Pasireotide—SSTR2—pituitary gland—brain cancer	0.0132	0.0229	CbGeAlD
Pasireotide—SSTR1—endocrine gland—brain cancer	0.0121	0.0208	CbGeAlD
Pasireotide—SSTR1—head—brain cancer	0.0119	0.0206	CbGeAlD
Pasireotide—SSTR3—brain—brain cancer	0.0109	0.0189	CbGeAlD
Pasireotide—SSTR1—central nervous system—brain cancer	0.0109	0.0188	CbGeAlD
Pasireotide—SSTR1—cerebellum—brain cancer	0.0106	0.0184	CbGeAlD
Pasireotide—SSTR2—endocrine gland—brain cancer	0.0102	0.0177	CbGeAlD
Pasireotide—SSTR2—head—brain cancer	0.0101	0.0175	CbGeAlD
Pasireotide—SSTR2—central nervous system—brain cancer	0.00924	0.016	CbGeAlD
Pasireotide—SSTR2—cerebellum—brain cancer	0.00903	0.0156	CbGeAlD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—HES5—brain cancer	0.00886	0.0339	CbGpPWpGaD
Pasireotide—SSTR1—brain—brain cancer	0.00862	0.0149	CbGeAlD
Pasireotide—SSTR2—brain—brain cancer	0.00733	0.0127	CbGeAlD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—HES5—brain cancer	0.00725	0.0277	CbGpPWpGaD
Pasireotide—SSTR2—GPCRs, Other—SMO—brain cancer	0.00563	0.0215	CbGpPWpGaD
Pasireotide—Gamma-glutamyltransferase increased—Temozolomide—brain cancer	0.00431	0.0269	CcSEcCtD
Pasireotide—SSTR3—GPCR ligand binding—PTCH2—brain cancer	0.00416	0.0159	CbGpPWpGaD
Pasireotide—Alopecia—Lomustine—brain cancer	0.0041	0.0256	CcSEcCtD
Pasireotide—SSTR1—GPCR ligand binding—PTCH2—brain cancer	0.00399	0.0153	CbGpPWpGaD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—ESR2—brain cancer	0.00377	0.0144	CbGpPWpGaD
Pasireotide—Injection site reaction—Carmustine—brain cancer	0.00365	0.0228	CcSEcCtD
Pasireotide—SSTR3—GPCR downstream signaling—OR14C36—brain cancer	0.00365	0.014	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—OR4C12—brain cancer	0.00365	0.014	CbGpPWpGaD
Pasireotide—SSTR5—GPCR ligand binding—PTCH2—brain cancer	0.00354	0.0135	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—OR14C36—brain cancer	0.0035	0.0134	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—OR4C12—brain cancer	0.0035	0.0134	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—OR14C36—brain cancer	0.00331	0.0127	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—OR4C12—brain cancer	0.00331	0.0127	CbGpPWpGaD
Pasireotide—SSTR2—GPCR ligand binding—PTCH2—brain cancer	0.00327	0.0125	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—OR14C36—brain cancer	0.00318	0.0122	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—OR4C12—brain cancer	0.00318	0.0122	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—OR14C36—brain cancer	0.0031	0.0119	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—OR4C12—brain cancer	0.0031	0.0119	CbGpPWpGaD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—ESR2—brain cancer	0.00309	0.0118	CbGpPWpGaD
Pasireotide—Diabetes mellitus—Carmustine—brain cancer	0.00307	0.0191	CcSEcCtD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—HES1—brain cancer	0.00293	0.0112	CbGpPWpGaD
Pasireotide—Decreased appetite—Lomustine—brain cancer	0.00287	0.0179	CcSEcCtD
Pasireotide—SSTR2—GPCR downstream signaling—OR14C36—brain cancer	0.00286	0.011	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—OR4C12—brain cancer	0.00286	0.011	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—OR4C12—brain cancer	0.00282	0.0108	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—OR14C36—brain cancer	0.00282	0.0108	CbGpPWpGaD
Pasireotide—Alopecia—Procarbazine—brain cancer	0.00261	0.0163	CcSEcCtD
Pasireotide—SSTR2—Signaling by GPCR—OR4C12—brain cancer	0.0026	0.00995	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—OR14C36—brain cancer	0.0026	0.00995	CbGpPWpGaD
Pasireotide—Hypokalaemia—Carmustine—brain cancer	0.00243	0.0152	CcSEcCtD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—HES1—brain cancer	0.0024	0.00917	CbGpPWpGaD
Pasireotide—Anaemia—Procarbazine—brain cancer	0.00237	0.0148	CcSEcCtD
Pasireotide—Dry skin—Temozolomide—brain cancer	0.00236	0.0147	CcSEcCtD
Pasireotide—Hypokalaemia—Temozolomide—brain cancer	0.00235	0.0146	CcSEcCtD
Pasireotide—Aspartate aminotransferase increased—Temozolomide—brain cancer	0.00232	0.0145	CcSEcCtD
Pasireotide—Alanine aminotransferase increased—Temozolomide—brain cancer	0.00227	0.0142	CcSEcCtD
Pasireotide—Abdominal distension—Temozolomide—brain cancer	0.00224	0.014	CcSEcCtD
Pasireotide—Hypertension—Procarbazine—brain cancer	0.00222	0.0138	CcSEcCtD
Pasireotide—Myalgia—Procarbazine—brain cancer	0.00219	0.0136	CcSEcCtD
Pasireotide—Arthralgia—Procarbazine—brain cancer	0.00219	0.0136	CcSEcCtD
Pasireotide—Anxiety—Procarbazine—brain cancer	0.00218	0.0136	CcSEcCtD
Pasireotide—SSTR3—GPCR ligand binding—SHH—brain cancer	0.00214	0.0082	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—PTCH2—brain cancer	0.00214	0.00817	CbGpPWpGaD
Pasireotide—Vomiting—Lomustine—brain cancer	0.0021	0.0131	CcSEcCtD
Pasireotide—Hyperglycaemia—Carmustine—brain cancer	0.00208	0.013	CcSEcCtD
Pasireotide—SSTR1—GPCR ligand binding—SHH—brain cancer	0.00206	0.00786	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—PTCH2—brain cancer	0.00205	0.00783	CbGpPWpGaD
Pasireotide—SSTR3—GPCR ligand binding—SMO—brain cancer	0.00203	0.00778	CbGpPWpGaD
Pasireotide—SSTR3—GPCR ligand binding—PTCH1—brain cancer	0.00203	0.00778	CbGpPWpGaD
Pasireotide—Alopecia—Hydroxyurea—brain cancer	0.00202	0.0126	CcSEcCtD
Pasireotide—Hyperglycaemia—Temozolomide—brain cancer	0.00201	0.0125	CcSEcCtD
Pasireotide—Nausea—Lomustine—brain cancer	0.00196	0.0122	CcSEcCtD
Pasireotide—SSTR3—Signaling Pathways—OR4C12—brain cancer	0.00196	0.00749	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—OR14C36—brain cancer	0.00196	0.00749	CbGpPWpGaD
Pasireotide—Hypotension—Procarbazine—brain cancer	0.00196	0.0122	CcSEcCtD
Pasireotide—SSTR1—GPCR ligand binding—PTCH1—brain cancer	0.00195	0.00746	CbGpPWpGaD
Pasireotide—SSTR1—GPCR ligand binding—SMO—brain cancer	0.00195	0.00746	CbGpPWpGaD
Pasireotide—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00191	0.0119	CcSEcCtD
Pasireotide—Insomnia—Procarbazine—brain cancer	0.00189	0.0118	CcSEcCtD
Pasireotide—SSTR1—Signaling Pathways—OR4C12—brain cancer	0.00188	0.00718	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—OR14C36—brain cancer	0.00188	0.00718	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—ABR—brain cancer	0.00185	0.00706	CbGpPWpGaD
Pasireotide—Anaemia—Hydroxyurea—brain cancer	0.00184	0.0115	CcSEcCtD
Pasireotide—SSTR5—GPCR ligand binding—SHH—brain cancer	0.00182	0.00697	CbGpPWpGaD
Pasireotide—Decreased appetite—Procarbazine—brain cancer	0.00182	0.0114	CcSEcCtD
Pasireotide—Alanine aminotransferase increased—Etoposide—brain cancer	0.00182	0.0114	CcSEcCtD
Pasireotide—Oedema peripheral—Carmustine—brain cancer	0.00182	0.0113	CcSEcCtD
Pasireotide—SSTR5—Signaling by GPCR—PTCH2—brain cancer	0.00182	0.00695	CbGpPWpGaD
Pasireotide—Fatigue—Procarbazine—brain cancer	0.00181	0.0113	CcSEcCtD
Pasireotide—Constipation—Procarbazine—brain cancer	0.00179	0.0112	CcSEcCtD
Pasireotide—SSTR1—GPCR downstream signaling—ABR—brain cancer	0.00177	0.00677	CbGpPWpGaD
Pasireotide—Oedema peripheral—Temozolomide—brain cancer	0.00176	0.011	CcSEcCtD
Pasireotide—SSTR5—GPCR ligand binding—PTCH1—brain cancer	0.00173	0.00661	CbGpPWpGaD
Pasireotide—SSTR5—GPCR ligand binding—SMO—brain cancer	0.00173	0.00661	CbGpPWpGaD
Pasireotide—Gastrointestinal pain—Procarbazine—brain cancer	0.00171	0.0107	CcSEcCtD
Pasireotide—SSTR2—GPCR ligand binding—SHH—brain cancer	0.00168	0.00644	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—ABR—brain cancer	0.00168	0.00641	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—PTCH2—brain cancer	0.00168	0.00641	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—OR4C12—brain cancer	0.00166	0.00637	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—DTX2—brain cancer	0.00166	0.00637	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—OR14C36—brain cancer	0.00166	0.00637	CbGpPWpGaD
Pasireotide—Abdominal pain—Procarbazine—brain cancer	0.00166	0.0103	CcSEcCtD
Pasireotide—Alopecia—Carmustine—brain cancer	0.00163	0.0102	CcSEcCtD
Pasireotide—SSTR1—Signaling by GPCR—ABR—brain cancer	0.00161	0.00615	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—DTX2—brain cancer	0.0016	0.00611	CbGpPWpGaD
Pasireotide—SSTR2—GPCR ligand binding—PTCH1—brain cancer	0.00159	0.0061	CbGpPWpGaD
Pasireotide—SSTR2—GPCR ligand binding—SMO—brain cancer	0.00159	0.0061	CbGpPWpGaD
Pasireotide—Alopecia—Temozolomide—brain cancer	0.00158	0.00984	CcSEcCtD
Pasireotide—SSTR5—GPCR downstream signaling—ABR—brain cancer	0.00157	0.006	CbGpPWpGaD
Pasireotide—Back pain—Carmustine—brain cancer	0.00155	0.0097	CcSEcCtD
Pasireotide—SSTR2—Signaling Pathways—OR4C12—brain cancer	0.00154	0.00588	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—OR14C36—brain cancer	0.00154	0.00588	CbGpPWpGaD
Pasireotide—Asthenia—Procarbazine—brain cancer	0.0015	0.00938	CcSEcCtD
Pasireotide—Back pain—Temozolomide—brain cancer	0.0015	0.00937	CcSEcCtD
Pasireotide—Anaemia—Carmustine—brain cancer	0.00148	0.00927	CcSEcCtD
Pasireotide—Pruritus—Procarbazine—brain cancer	0.00148	0.00925	CcSEcCtD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—CTNNB1—brain cancer	0.00147	0.00562	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—ABR—brain cancer	0.00145	0.00554	CbGpPWpGaD
Pasireotide—Anaemia—Temozolomide—brain cancer	0.00143	0.00896	CcSEcCtD
Pasireotide—Diarrhoea—Procarbazine—brain cancer	0.00143	0.00895	CcSEcCtD
Pasireotide—SSTR5—Signaling by GPCR—ABR—brain cancer	0.00143	0.00545	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—DTX2—brain cancer	0.00142	0.00542	CbGpPWpGaD
Pasireotide—Decreased appetite—Hydroxyurea—brain cancer	0.00141	0.0088	CcSEcCtD
Pasireotide—Fatigue—Hydroxyurea—brain cancer	0.0014	0.00873	CcSEcCtD
Pasireotide—Vertigo—Temozolomide—brain cancer	0.00139	0.00871	CcSEcCtD
Pasireotide—Hypertension—Carmustine—brain cancer	0.00139	0.00866	CcSEcCtD
Pasireotide—Constipation—Hydroxyurea—brain cancer	0.00139	0.00866	CcSEcCtD
Pasireotide—Dizziness—Procarbazine—brain cancer	0.00139	0.00865	CcSEcCtD
Pasireotide—Myalgia—Carmustine—brain cancer	0.00137	0.00854	CcSEcCtD
Pasireotide—Anxiety—Carmustine—brain cancer	0.00136	0.00851	CcSEcCtD
Pasireotide—Hypertension—Temozolomide—brain cancer	0.00134	0.00837	CcSEcCtD
Pasireotide—Vomiting—Procarbazine—brain cancer	0.00133	0.00832	CcSEcCtD
Pasireotide—Arthralgia—Temozolomide—brain cancer	0.00132	0.00825	CcSEcCtD
Pasireotide—Myalgia—Temozolomide—brain cancer	0.00132	0.00825	CcSEcCtD
Pasireotide—Anxiety—Temozolomide—brain cancer	0.00132	0.00822	CcSEcCtD
Pasireotide—SSTR2—Signaling by GPCR—ABR—brain cancer	0.00132	0.00503	CbGpPWpGaD
Pasireotide—Headache—Procarbazine—brain cancer	0.00131	0.00819	CcSEcCtD
Pasireotide—SSTR2—Signaling Pathways—DTX2—brain cancer	0.00131	0.005	CbGpPWpGaD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—VEGFA—brain cancer	0.00129	0.00495	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PTCH2—brain cancer	0.00126	0.00483	CbGpPWpGaD
Pasireotide—Alopecia—Etoposide—brain cancer	0.00126	0.00787	CcSEcCtD
Pasireotide—Nausea—Procarbazine—brain cancer	0.00124	0.00777	CcSEcCtD
Pasireotide—Hypotension—Carmustine—brain cancer	0.00122	0.00765	CcSEcCtD
Pasireotide—SSTR3—Signaling Pathways—HES5—brain cancer	0.00122	0.00468	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PTCH2—brain cancer	0.00121	0.00463	CbGpPWpGaD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—CTNNB1—brain cancer	0.0012	0.0046	CbGpPWpGaD
Pasireotide—Back pain—Etoposide—brain cancer	0.0012	0.0075	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Carmustine—brain cancer	0.00119	0.00746	CcSEcCtD
Pasireotide—SSTR3—Signaling Pathways—STRADA—brain cancer	0.00119	0.00454	CbGpPWpGaD
Pasireotide—Insomnia—Carmustine—brain cancer	0.00119	0.0074	CcSEcCtD
Pasireotide—SSTR1—Signaling Pathways—HES5—brain cancer	0.00117	0.00448	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—TRPC6—brain cancer	0.00117	0.00447	CbGpPWpGaD
Pasireotide—Asthenia—Hydroxyurea—brain cancer	0.00116	0.00726	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Temozolomide—brain cancer	0.00115	0.0072	CcSEcCtD
Pasireotide—Anaemia—Etoposide—brain cancer	0.00115	0.00717	CcSEcCtD
Pasireotide—Insomnia—Temozolomide—brain cancer	0.00115	0.00715	CcSEcCtD
Pasireotide—Decreased appetite—Carmustine—brain cancer	0.00114	0.00711	CcSEcCtD
Pasireotide—SSTR1—Signaling Pathways—STRADA—brain cancer	0.00114	0.00435	CbGpPWpGaD
Pasireotide—Constipation—Carmustine—brain cancer	0.00112	0.007	CcSEcCtD
Pasireotide—SSTR1—GPCR downstream signaling—TRPC6—brain cancer	0.00112	0.00429	CbGpPWpGaD
Pasireotide—Vertigo—Etoposide—brain cancer	0.00112	0.00697	CcSEcCtD
Pasireotide—Diarrhoea—Hydroxyurea—brain cancer	0.00111	0.00693	CcSEcCtD
Pasireotide—Decreased appetite—Temozolomide—brain cancer	0.0011	0.00687	CcSEcCtD
Pasireotide—SSTR3—Signaling by GPCR—SHH—brain cancer	0.0011	0.00421	CbGpPWpGaD
Pasireotide—Fatigue—Temozolomide—brain cancer	0.00109	0.00682	CcSEcCtD
Pasireotide—Constipation—Temozolomide—brain cancer	0.00108	0.00676	CcSEcCtD
Pasireotide—SSTR5—Signaling Pathways—PTCH2—brain cancer	0.00107	0.0041	CbGpPWpGaD
Pasireotide—Hypertension—Etoposide—brain cancer	0.00107	0.00669	CcSEcCtD
Pasireotide—Dizziness—Hydroxyurea—brain cancer	0.00107	0.00669	CcSEcCtD
Pasireotide—Gastrointestinal pain—Carmustine—brain cancer	0.00107	0.00669	CcSEcCtD
Pasireotide—SSTR3—Signaling by GPCR—TRPC6—brain cancer	0.00106	0.00406	CbGpPWpGaD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—VEGFA—brain cancer	0.00106	0.00405	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—SHH—brain cancer	0.00105	0.00404	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—SMO—brain cancer	0.00104	0.00399	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—PTCH1—brain cancer	0.00104	0.00399	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—HES5—brain cancer	0.00104	0.00398	CbGpPWpGaD
Pasireotide—Abdominal pain—Carmustine—brain cancer	0.00104	0.00647	CcSEcCtD
Pasireotide—Gastrointestinal pain—Temozolomide—brain cancer	0.00104	0.00647	CcSEcCtD
Pasireotide—Vomiting—Hydroxyurea—brain cancer	0.00103	0.00644	CcSEcCtD
Pasireotide—SSTR1—Signaling by GPCR—TRPC6—brain cancer	0.00102	0.00389	CbGpPWpGaD
Pasireotide—Headache—Hydroxyurea—brain cancer	0.00102	0.00634	CcSEcCtD
Pasireotide—SSTR5—Signaling Pathways—STRADA—brain cancer	0.00101	0.00386	CbGpPWpGaD
Pasireotide—Abdominal pain—Temozolomide—brain cancer	0.001	0.00625	CcSEcCtD
Pasireotide—SSTR1—Signaling by GPCR—SMO—brain cancer	0.001	0.00383	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—PTCH1—brain cancer	0.001	0.00383	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—TRPC6—brain cancer	0.000993	0.0038	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PTCH2—brain cancer	0.00099	0.00379	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—ABR—brain cancer	0.00099	0.00379	CbGpPWpGaD
Pasireotide—Nausea—Hydroxyurea—brain cancer	0.000963	0.00601	CcSEcCtD
Pasireotide—SSTR2—Signaling Pathways—HES5—brain cancer	0.000959	0.00367	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—GLI2—brain cancer	0.000956	0.00366	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—ABR—brain cancer	0.000949	0.00363	CbGpPWpGaD
Pasireotide—Hypotension—Etoposide—brain cancer	0.000947	0.00591	CcSEcCtD
Pasireotide—Asthenia—Carmustine—brain cancer	0.00094	0.00587	CcSEcCtD
Pasireotide—SSTR5—Signaling by GPCR—SHH—brain cancer	0.000936	0.00358	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—STRADA—brain cancer	0.000931	0.00356	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—TRPC6—brain cancer	0.000917	0.00351	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—GLI2—brain cancer	0.000917	0.00351	CbGpPWpGaD
Pasireotide—Asthenia—Temozolomide—brain cancer	0.000909	0.00567	CcSEcCtD
Pasireotide—SSTR5—Signaling by GPCR—TRPC6—brain cancer	0.000902	0.00345	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—GLI1—brain cancer	0.000899	0.00344	CbGpPWpGaD
Pasireotide—Diarrhoea—Carmustine—brain cancer	0.000897	0.0056	CcSEcCtD
Pasireotide—Pruritus—Temozolomide—brain cancer	0.000896	0.00559	CcSEcCtD
Pasireotide—SSTR5—Signaling by GPCR—PTCH1—brain cancer	0.000887	0.00339	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—SMO—brain cancer	0.000887	0.00339	CbGpPWpGaD
Pasireotide—Decreased appetite—Etoposide—brain cancer	0.000881	0.0055	CcSEcCtD
Pasireotide—SSTR3—GPCR downstream signaling—VAV1—brain cancer	0.000875	0.00335	CbGpPWpGaD
Pasireotide—Fatigue—Etoposide—brain cancer	0.000874	0.00546	CcSEcCtD
Pasireotide—Dizziness—Carmustine—brain cancer	0.000867	0.00541	CcSEcCtD
Pasireotide—Constipation—Etoposide—brain cancer	0.000867	0.00541	CcSEcCtD
Pasireotide—Diarrhoea—Temozolomide—brain cancer	0.000867	0.00541	CcSEcCtD
Pasireotide—SSTR2—Signaling by GPCR—SHH—brain cancer	0.000863	0.0033	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—GLI1—brain cancer	0.000862	0.0033	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—SUFU—brain cancer	0.000852	0.00326	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—ABR—brain cancer	0.000842	0.00322	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—VAV1—brain cancer	0.000839	0.00321	CbGpPWpGaD
Pasireotide—Dizziness—Temozolomide—brain cancer	0.000838	0.00523	CcSEcCtD
Pasireotide—Vomiting—Carmustine—brain cancer	0.000833	0.0052	CcSEcCtD
Pasireotide—SSTR2—Signaling by GPCR—TRPC6—brain cancer	0.000833	0.00319	CbGpPWpGaD
Pasireotide—Gastrointestinal pain—Etoposide—brain cancer	0.000829	0.00517	CcSEcCtD
Pasireotide—SSTR3—Signaling Pathways—GFAP—brain cancer	0.000822	0.00315	CbGpPWpGaD
Pasireotide—Headache—Carmustine—brain cancer	0.000821	0.00513	CcSEcCtD
Pasireotide—SSTR2—Signaling by GPCR—SMO—brain cancer	0.000818	0.00313	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—PTCH1—brain cancer	0.000818	0.00313	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—SUFU—brain cancer	0.000817	0.00313	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—GLI2—brain cancer	0.000813	0.00311	CbGpPWpGaD
Pasireotide—Vomiting—Temozolomide—brain cancer	0.000805	0.00503	CcSEcCtD
Pasireotide—Abdominal pain—Etoposide—brain cancer	0.000801	0.005	CcSEcCtD
Pasireotide—SSTR3—Signaling by GPCR—VAV1—brain cancer	0.000795	0.00304	CbGpPWpGaD
Pasireotide—Headache—Temozolomide—brain cancer	0.000793	0.00495	CcSEcCtD
Pasireotide—SSTR1—Signaling Pathways—GFAP—brain cancer	0.000788	0.00302	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—HEY1—brain cancer	0.000779	0.00298	CbGpPWpGaD
Pasireotide—Nausea—Carmustine—brain cancer	0.000778	0.00486	CcSEcCtD
Pasireotide—SSTR2—Signaling Pathways—ABR—brain cancer	0.000777	0.00297	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—DLL1—brain cancer	0.000764	0.00292	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—GLI1—brain cancer	0.000764	0.00292	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—VAV1—brain cancer	0.000762	0.00292	CbGpPWpGaD
Pasireotide—Nausea—Temozolomide—brain cancer	0.000752	0.0047	CcSEcCtD
Pasireotide—SSTR2—Signaling Pathways—GLI2—brain cancer	0.00075	0.00287	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—HEY1—brain cancer	0.000747	0.00286	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—VAV1—brain cancer	0.000744	0.00285	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—DLL1—brain cancer	0.000733	0.0028	CbGpPWpGaD
Pasireotide—Asthenia—Etoposide—brain cancer	0.000727	0.00454	CcSEcCtD
Pasireotide—SSTR5—Signaling Pathways—SUFU—brain cancer	0.000725	0.00277	CbGpPWpGaD
Pasireotide—Pruritus—Etoposide—brain cancer	0.000717	0.00448	CcSEcCtD
Pasireotide—SSTR2—Signaling Pathways—GLI1—brain cancer	0.000705	0.0027	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—GFAP—brain cancer	0.000699	0.00267	CbGpPWpGaD
Pasireotide—Diarrhoea—Etoposide—brain cancer	0.000693	0.00433	CcSEcCtD
Pasireotide—SSTR2—GPCR downstream signaling—VAV1—brain cancer	0.000687	0.00263	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—VAV1—brain cancer	0.000676	0.00259	CbGpPWpGaD
Pasireotide—Dizziness—Etoposide—brain cancer	0.00067	0.00418	CcSEcCtD
Pasireotide—SSTR2—Signaling Pathways—SUFU—brain cancer	0.000669	0.00256	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—HEY1—brain cancer	0.000663	0.00254	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—SHH—brain cancer	0.00065	0.00249	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—DLL1—brain cancer	0.00065	0.00249	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—GFAP—brain cancer	0.000645	0.00247	CbGpPWpGaD
Pasireotide—Vomiting—Etoposide—brain cancer	0.000644	0.00402	CcSEcCtD
Pasireotide—Headache—Etoposide—brain cancer	0.000635	0.00396	CcSEcCtD
Pasireotide—SSTR3—Signaling Pathways—TRPC6—brain cancer	0.000627	0.0024	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—VAV1—brain cancer	0.000624	0.00239	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—SHH—brain cancer	0.000623	0.00238	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PTCH1—brain cancer	0.000616	0.00236	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—SMO—brain cancer	0.000616	0.00236	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—HEY1—brain cancer	0.000612	0.00234	CbGpPWpGaD
Pasireotide—Nausea—Etoposide—brain cancer	0.000602	0.00376	CcSEcCtD
Pasireotide—SSTR1—Signaling Pathways—TRPC6—brain cancer	0.000601	0.0023	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—DLL1—brain cancer	0.0006	0.0023	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—SMO—brain cancer	0.000591	0.00226	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PTCH1—brain cancer	0.000591	0.00226	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—PIK3CG—brain cancer	0.000556	0.00213	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—SHH—brain cancer	0.000553	0.00211	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—TRPC6—brain cancer	0.000533	0.00204	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—PIK3CG—brain cancer	0.000533	0.00204	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—SMO—brain cancer	0.000524	0.002	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PTCH1—brain cancer	0.000524	0.002	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—SHH—brain cancer	0.00051	0.00195	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—PIK3CG—brain cancer	0.000505	0.00193	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—NOTCH2—brain cancer	0.000493	0.00188	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—TRPC6—brain cancer	0.000492	0.00188	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—PIK3CG—brain cancer	0.000484	0.00185	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—SMO—brain cancer	0.000483	0.00185	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PTCH1—brain cancer	0.000483	0.00185	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—PIK3CG—brain cancer	0.000473	0.00181	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—NOTCH2—brain cancer	0.000472	0.00181	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—VAV1—brain cancer	0.00047	0.0018	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—VAV1—brain cancer	0.00045	0.00172	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—PIK3CG—brain cancer	0.000436	0.00167	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—PIK3CG—brain cancer	0.000429	0.00164	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—NOTCH2—brain cancer	0.000419	0.0016	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—HES1—brain cancer	0.000404	0.00155	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—VAV1—brain cancer	0.000399	0.00153	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—PIK3CG—brain cancer	0.000396	0.00152	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—IL2—brain cancer	0.000391	0.0015	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—HES1—brain cancer	0.000387	0.00148	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—NOTCH2—brain cancer	0.000387	0.00148	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PDGFRA—brain cancer	0.000385	0.00147	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—IL2—brain cancer	0.000375	0.00143	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—SPP1—brain cancer	0.000373	0.00143	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PDGFRA—brain cancer	0.000369	0.00141	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—VAV1—brain cancer	0.000368	0.00141	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—SPP1—brain cancer	0.000358	0.00137	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—IL2—brain cancer	0.000355	0.00136	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—HES1—brain cancer	0.000343	0.00131	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—IL2—brain cancer	0.000341	0.0013	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—IRS2—brain cancer	0.000338	0.00129	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—IL2—brain cancer	0.000333	0.00127	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PDGFRA—brain cancer	0.000327	0.00125	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—IRS2—brain cancer	0.000324	0.00124	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—SPP1—brain cancer	0.000317	0.00121	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—HES1—brain cancer	0.000317	0.00121	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—IL2—brain cancer	0.000307	0.00117	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—IL2—brain cancer	0.000302	0.00116	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PDGFRA—brain cancer	0.000302	0.00115	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—APC—brain cancer	0.000298	0.00114	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PIK3CG—brain cancer	0.000298	0.00114	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—SPP1—brain cancer	0.000293	0.00112	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—IRS2—brain cancer	0.000287	0.0011	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—APC—brain cancer	0.000286	0.00109	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PIK3CG—brain cancer	0.000286	0.00109	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—IL2—brain cancer	0.000279	0.00107	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—EGFR—brain cancer	0.000272	0.00104	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—IRS2—brain cancer	0.000265	0.00101	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—EGFR—brain cancer	0.00026	0.000996	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—APC—brain cancer	0.000254	0.00097	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PIK3CG—brain cancer	0.000254	0.00097	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—APC—brain cancer	0.000234	0.000895	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PIK3CG—brain cancer	0.000234	0.000895	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—RELA—brain cancer	0.000233	0.000891	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—ERBB2—brain cancer	0.000232	0.000886	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—EGFR—brain cancer	0.000231	0.000884	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—RELA—brain cancer	0.000223	0.000855	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—ERBB2—brain cancer	0.000222	0.000849	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—EGFR—brain cancer	0.000213	0.000816	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—IL2—brain cancer	0.00021	0.000803	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CCND1—brain cancer	0.000205	0.000783	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CTNNB1—brain cancer	0.000203	0.000775	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—IL2—brain cancer	0.000201	0.00077	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—RELA—brain cancer	0.000198	0.000758	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—ERBB2—brain cancer	0.000197	0.000753	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CCND1—brain cancer	0.000196	0.00075	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CTNNB1—brain cancer	0.000194	0.000743	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—RELA—brain cancer	0.000183	0.000699	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—ERBB2—brain cancer	0.000182	0.000695	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—IL2—brain cancer	0.000178	0.000683	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—VEGFA—brain cancer	0.000178	0.000682	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—STAT3—brain cancer	0.000177	0.000676	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CCND1—brain cancer	0.000174	0.000665	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CTNNB1—brain cancer	0.000172	0.000659	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—VEGFA—brain cancer	0.000171	0.000654	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—STAT3—brain cancer	0.000169	0.000648	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—IL2—brain cancer	0.000165	0.00063	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—MYC—brain cancer	0.000164	0.000628	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CCND1—brain cancer	0.00016	0.000614	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—EGFR—brain cancer	0.00016	0.000614	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CTNNB1—brain cancer	0.000159	0.000608	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—MYC—brain cancer	0.000157	0.000602	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—EGFR—brain cancer	0.000154	0.000589	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—VEGFA—brain cancer	0.000152	0.00058	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—STAT3—brain cancer	0.00015	0.000574	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—VEGFA—brain cancer	0.00014	0.000535	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—MYC—brain cancer	0.000139	0.000534	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—STAT3—brain cancer	0.000139	0.00053	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—EGFR—brain cancer	0.000136	0.000522	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—TP53—brain cancer	0.000135	0.000516	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—TP53—brain cancer	0.000129	0.000494	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—MYC—brain cancer	0.000129	0.000493	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—EGFR—brain cancer	0.000126	0.000482	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—TP53—brain cancer	0.000115	0.000438	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—TP53—brain cancer	0.000106	0.000405	CbGpPWpGaD
